RET and medullary thyroid gland carcinoma: In RET positive MTC, among several miRNAs identified, eight were up-regulated and one of them, miR-153-3p, was found to have tumor suppressor function, increasing the antiproliferative efficacy of cabozantinib by acting on factors involved in the mTOR pathway [117].